O	0	4	LMP1	LMP1	NN	B-NP
O	5	7	of	of	IN	B-PP
O	8	15	Epstein	Epstein	NNP	B-NP
O	15	16	-	-	HYPH	I-NP
O	16	20	Barr	Barr	NNP	I-NP
O	21	26	virus	virus	NN	I-NP
O	27	34	induces	induce	VBZ	B-VP
O	35	48	proliferation	proliferation	NN	B-NP
O	49	51	of	of	IN	B-PP
O	52	59	primary	primary	JJ	B-NP
O	60	65	mouse	mouse	NN	I-NP
B-Cell	66	75	embryonic	embryonic	JJ	I-NP
I-Cell	76	87	fibroblasts	fibroblast	NNS	I-NP
O	88	91	and	and	CC	O
O	92	105	cooperatively	cooperatively	RB	B-VP
O	106	116	transforms	transform	VBZ	I-VP
O	117	120	the	the	DT	B-NP
B-Cell	121	126	cells	cell	NNS	I-NP
O	127	131	with	with	IN	B-PP
O	132	133	a	a	DT	B-NP
O	134	137	p16	p16	NN	I-NP
O	137	138	-	-	HYPH	B-NP
O	138	149	insensitive	insensitive	JJ	I-NP
O	150	154	CDK4	CDK4	NN	I-NP
O	155	163	oncogene	oncogene	NN	I-NP
O	163	164	.	.	.	O

O	166	169	The	The	DT	B-NP
O	170	176	latent	latent	JJ	I-NP
O	177	185	membrane	membrane	NN	I-NP
O	186	193	protein	protein	NN	I-NP
O	194	198	LMP1	LMP1	NN	I-NP
O	199	201	of	of	IN	B-PP
O	202	209	Epstein	Epstein	NNP	B-NP
O	209	210	-	-	HYPH	I-NP
O	210	214	Barr	Barr	NNP	I-NP
O	215	220	virus	virus	NN	I-NP
O	221	222	(	(	(	O
O	222	225	EBV	EBV	NN	B-NP
O	225	226	)	)	)	O
O	227	229	is	be	VBZ	B-VP
O	230	235	often	often	RB	B-ADVP
O	236	243	present	present	JJ	B-ADJP
O	244	246	in	in	IN	B-PP
O	247	250	EBV	EBV	NN	B-NP
O	250	251	-	-	HYPH	B-NP
O	251	261	associated	associate	VBN	I-NP
B-Cancer	262	274	malignancies	malignancy	NNS	I-NP
O	275	284	including	include	VBG	B-PP
B-Cancer	285	299	nasopharyngeal	nasopharyngeal	JJ	B-NP
I-Cancer	300	309	carcinoma	carcinoma	NN	I-NP
O	310	313	and	and	CC	I-NP
B-Cancer	314	321	Hodgkin	Hodgkin	NN	I-NP
I-Cancer	321	322	'	'	''	I-NP
I-Cancer	322	323	s	s	JJ	I-NP
I-Cancer	324	332	lymphoma	lymphoma	NN	I-NP
O	332	333	.	.	.	O

O	334	342	Previous	Previous	JJ	B-NP
O	343	347	work	work	NN	I-NP
O	348	360	demonstrates	demonstrate	VBZ	B-VP
O	361	365	that	that	IN	B-SBAR
O	366	369	the	the	DT	B-NP
O	370	374	LMP1	LMP1	NN	I-NP
O	375	379	gene	gene	NN	I-NP
O	380	382	of	of	IN	B-PP
O	383	386	EBV	EBV	NN	B-NP
O	387	389	is	be	VBZ	B-VP
O	390	400	sufficient	sufficient	JJ	B-ADJP
O	401	403	to	to	TO	B-VP
O	404	413	transform	transform	VB	I-VP
O	414	421	certain	certain	JJ	B-NP
O	422	433	established	established	JJ	I-NP
O	434	440	rodent	rodent	NN	I-NP
B-Cell	441	451	fibroblast	fibroblast	NN	I-NP
I-Cell	452	456	cell	cell	NN	I-NP
I-Cell	457	462	lines	line	NNS	I-NP
O	463	466	and	and	CC	O
O	467	469	to	to	TO	B-VP
O	470	476	induce	induce	VB	I-VP
O	477	480	the	the	DT	B-NP
O	481	495	tumorigenicity	tumorigenicity	NN	I-NP
O	496	498	of	of	IN	B-PP
O	499	503	some	some	DT	B-NP
O	504	509	human	human	JJ	I-NP
B-Cell	510	520	epithelial	epithelial	JJ	I-NP
I-Cell	521	525	cell	cell	NN	I-NP
I-Cell	526	531	lines	line	NNS	I-NP
O	531	532	.	.	.	O

O	533	535	In	In	IN	B-PP
O	536	544	addition	addition	NN	B-NP
O	544	545	,	,	,	O
O	546	550	LMP1	LMP1	NN	B-NP
O	551	556	plays	play	VBZ	B-VP
O	557	568	pleiotropic	pleiotropic	JJ	B-NP
O	569	574	roles	role	NNS	I-NP
O	575	577	in	in	IN	B-PP
B-Cell	578	582	cell	cell	NN	B-NP
O	583	589	growth	growth	NN	I-NP
O	590	596	arrest	arrest	NN	I-NP
O	596	597	,	,	,	O
O	598	613	differentiation	differentiation	NN	B-NP
O	613	614	,	,	,	O
O	615	618	and	and	CC	O
O	619	628	apoptosis	apoptosis	NN	B-NP
O	628	629	,	,	,	O
O	630	639	depending	depend	VBG	B-PP
O	640	642	on	on	IN	B-PP
O	643	646	the	the	DT	B-NP
O	647	657	background	background	NN	I-NP
O	658	660	of	of	IN	B-PP
O	661	664	the	the	DT	B-NP
O	665	671	target	target	NN	I-NP
B-Cell	672	677	cells	cell	NNS	I-NP
O	677	678	.	.	.	O

O	679	681	To	To	TO	B-VP
O	682	689	examine	examine	VB	I-VP
O	690	693	the	the	DT	B-NP
O	694	699	roles	role	NNS	I-NP
O	700	702	of	of	IN	B-PP
O	703	707	LMP1	LMP1	NN	B-NP
O	708	710	in	in	IN	B-PP
B-Cell	711	715	cell	cell	NN	B-NP
O	716	729	proliferation	proliferation	NN	I-NP
O	730	733	and	and	CC	O
O	734	740	growth	growth	NN	B-NP
O	741	751	regulation	regulation	NN	I-NP
O	752	754	in	in	IN	B-PP
O	755	762	primary	primary	JJ	B-NP
B-Cell	763	770	culture	culture	NN	I-NP
I-Cell	771	776	cells	cell	NNS	I-NP
O	776	777	,	,	,	O
O	778	780	we	we	PRP	B-NP
O	781	792	constructed	construct	VBD	B-VP
O	793	794	a	a	DT	B-NP
O	795	806	recombinant	recombinant	JJ	I-NP
O	807	817	retrovirus	retrovirus	NN	I-NP
O	818	828	containing	contain	VBG	B-VP
O	829	831	an	an	DT	B-NP
O	832	836	LMP1	LMP1	NN	I-NP
O	837	841	gene	gene	NN	I-NP
O	841	842	.	.	.	O

O	843	847	With	With	IN	B-PP
O	848	852	this	this	DT	B-NP
O	853	863	retrovirus	retrovirus	NN	I-NP
O	863	864	,	,	,	O
O	865	869	LMP1	LMP1	NN	B-NP
O	870	873	was	be	VBD	B-VP
O	874	879	shown	show	VBN	I-VP
O	880	882	to	to	TO	I-VP
O	883	892	stimulate	stimulate	VB	I-VP
O	893	896	the	the	DT	B-NP
O	897	910	proliferation	proliferation	NN	I-NP
O	911	913	of	of	IN	B-PP
O	914	921	primary	primary	JJ	B-NP
O	922	927	mouse	mouse	NN	I-NP
B-Cell	928	937	embryonic	embryonic	JJ	I-NP
I-Cell	938	949	fibroblasts	fibroblast	NNS	I-NP
O	950	951	(	(	(	O
B-Cell	951	954	MEF	MEF	NN	B-NP
I-Cell	955	960	cells	cell	NNS	I-NP
O	960	961	)	)	)	O
O	961	962	.	.	.	O

O	963	965	It	It	PRP	B-NP
O	966	969	has	have	VBZ	B-VP
O	970	971	a	a	DT	B-NP
O	972	981	mitogenic	mitogenic	JJ	I-NP
O	982	990	activity	activity	NN	I-NP
O	991	994	for	for	IN	B-PP
B-Cell	995	998	MEF	MEF	NN	B-NP
I-Cell	999	1004	cells	cell	NNS	I-NP
O	1004	1005	,	,	,	O
O	1006	1008	as	as	IN	B-SBAR
O	1009	1021	demonstrated	demonstrate	VBN	B-VP
O	1022	1024	by	by	IN	B-PP
O	1025	1027	an	an	DT	B-NP
O	1028	1037	immediate	immediate	JJ	I-NP
O	1038	1047	induction	induction	NN	I-NP
O	1048	1050	of	of	IN	B-PP
B-Cell	1051	1055	cell	cell	NN	B-NP
O	1056	1064	doubling	doubling	NN	I-NP
O	1065	1069	time	time	NN	I-NP
O	1069	1070	.	.	.	O

O	1071	1073	In	In	IN	B-PP
O	1074	1082	addition	addition	NN	B-NP
O	1082	1083	,	,	,	O
O	1084	1086	it	it	PRP	B-NP
O	1087	1100	significantly	significantly	RB	B-ADVP
O	1101	1108	extends	extend	VBZ	B-VP
O	1109	1112	the	the	DT	B-NP
O	1113	1120	passage	passage	NN	I-NP
O	1121	1127	number	number	NN	I-NP
O	1128	1130	of	of	IN	B-PP
B-Cell	1131	1134	MEF	MEF	NN	B-NP
I-Cell	1135	1140	cells	cell	NNS	I-NP
O	1141	1143	to	to	TO	B-PP
O	1144	1148	more	more	JJR	B-NP
O	1149	1153	than	than	IN	I-NP
O	1154	1156	30	30	CD	I-NP
O	1157	1162	after	after	IN	B-PP
O	1163	1173	retroviral	retroviral	JJ	B-NP
O	1174	1183	infection	infection	NN	I-NP
O	1183	1184	,	,	,	O
O	1185	1193	compared	compare	VBN	B-PP
O	1194	1198	with	with	IN	B-PP
O	1199	1203	less	less	JJR	B-NP
O	1204	1208	than	than	IN	I-NP
O	1209	1210	5	5	CD	I-NP
O	1211	1214	for	for	IN	B-PP
O	1215	1225	uninfected	uninfected	JJ	B-NP
B-Cell	1226	1229	MEF	MEF	NN	I-NP
I-Cell	1230	1235	cells	cell	NNS	I-NP
O	1235	1236	.	.	.	O

O	1237	1248	Furthermore	Furthermore	RB	B-ADVP
O	1248	1249	,	,	,	O
O	1250	1254	LMP1	LMP1	NN	B-NP
O	1255	1265	cooperates	cooperate	VBZ	B-VP
O	1266	1270	with	with	IN	B-PP
O	1271	1272	a	a	DT	B-NP
O	1273	1276	p16	p16	NN	I-NP
O	1276	1277	-	-	HYPH	B-NP
O	1277	1288	insensitive	insensitive	JJ	I-NP
O	1289	1293	CDK4	CDK4	NN	I-NP
O	1293	1294	(	(	(	O
O	1294	1298	R24C	R24C	NN	B-NP
O	1298	1299	)	)	)	O
O	1300	1308	oncogene	oncogene	NN	B-NP
O	1309	1311	in	in	IN	B-PP
O	1312	1324	transforming	transform	VBG	B-VP
B-Cell	1325	1328	MEF	MEF	NN	B-NP
I-Cell	1329	1334	cells	cell	NNS	I-NP
O	1334	1335	.	.	.	O

O	1336	1339	Our	Our	PRP$	B-NP
O	1340	1347	results	result	NNS	I-NP
O	1348	1355	provide	provide	VBP	B-VP
O	1356	1359	the	the	DT	B-NP
O	1360	1365	first	first	JJ	I-NP
O	1366	1374	evidence	evidence	NN	I-NP
O	1375	1377	of	of	IN	B-PP
O	1378	1381	the	the	DT	B-NP
O	1382	1391	abilities	ability	NNS	I-NP
O	1392	1394	of	of	IN	B-PP
O	1395	1398	the	the	DT	B-NP
O	1399	1403	LMP1	LMP1	NN	I-NP
O	1404	1408	gene	gene	NN	I-NP
O	1408	1409	,	,	,	O
O	1410	1416	acting	act	VBG	B-VP
O	1417	1422	alone	alone	RB	B-ADVP
O	1422	1423	,	,	,	O
O	1424	1426	to	to	TO	B-VP
O	1427	1438	effectively	effectively	RB	I-VP
O	1439	1445	induce	induce	VB	I-VP
O	1446	1449	the	the	DT	B-NP
O	1450	1463	proliferation	proliferation	NN	I-NP
O	1464	1466	of	of	IN	B-PP
O	1467	1474	primary	primary	JJ	B-NP
B-Cell	1475	1478	MEF	MEF	NN	I-NP
I-Cell	1479	1484	cells	cell	NNS	I-NP
O	1485	1488	and	and	CC	B-PP
O	1489	1491	of	of	IN	B-PP
O	1492	1495	its	its	PRP$	B-NP
O	1496	1509	cooperativity	cooperativity	NN	I-NP
O	1510	1514	with	with	IN	B-PP
O	1515	1522	another	another	DT	B-NP
B-Cell	1523	1531	cellular	cellular	JJ	I-NP
O	1532	1540	oncogene	oncogene	NN	I-NP
O	1541	1543	in	in	IN	B-PP
O	1544	1556	transforming	transform	VBG	B-VP
O	1557	1564	primary	primary	JJ	B-NP
B-Cell	1565	1570	cells	cell	NNS	I-NP
O	1570	1571	.	.	.	O

